Articles On Rhinomed (ASX:RNO)

As nerves mount for players on both NRL Grand Final sides preparing to line up at Staiudm Australia on Sunday night, it’s worth remembering the myriad enterprises that enable sportspeople to leap higher and kick further – while also tending...

Benchmark set to end the day down 1.5% Small caps smashed down 4.2% Greenwing up 70% on Chinese investment   Look. No-one likes Monday’s except possibly the last four or five Prime Ministers. I definitely sense S Morrison and K Rudd and c...

Cambridge says cannabis smokers are not actually lazy, that’s a myth USyd wants to test home-grown cannabis in the ACT Incannex joins the big leagues S&P/ASX300 index   It turns out that the lazy stoner stereotype is actually a myth,...

Researchers say data shows transition from illicit to legal use of cannabis Medicinal users are at 37%, compared to 2.5% in 2018 Regulations, quality control and costs still barriers for legal week users   New research from the University...

Did you know that the nasal anatomy of a four-year-old kid is very different to that of a 12-year-old – which is different again to that of a fully-fledged adult? We didn’t – but now we nose. For Rhinomed (ASX:RNO), this information is more...

Ice-T is opening a cannabis dispensary in New Jersey this year Snoop Dogg’s venture capital firm led a seed funding round for TSUMo Snacks Incannex ramps up development and manufacturing of IHL-216A drug New Jersey has given Ice-T the gre...

ShareCafeGlobal Biotech Turnaround Looks to Be Underway Signs of life are emerging in the global biotech sector, after the longest and sharpest downturn in history that was so severe it left hundreds US companies trading below cash backing....

Mysterious pink glow over Mildura Thailand businesses go nuts for CBD desserts and bubble tea ECS nabs $2m commercial loan facility to invest in new capacity ICYMI a mysterious pink glow above Mildura sent residents into a bit of a frenzy...

US FDA approves the first clinical trial using naturally derived psychedelic drugs It could open possibilities for other clinical trials to follow suit Best and worst biotechs over the past month In a ground-breaking development, the US F...

Highlights Rhinomed has secured a two-year supply agreement for Rhinoswabs and Rhinoswab Juniors from SureScreen Australia The agreement is for a minimum of 10 million Rhinomed swabs The development holds the potential to represent mo...

Rhinomed (ASX:RNO) has finalised an exclusive supply agreement with SureScreen Australia to supply Rhinoswabs and Rhinoswab Juniors for inclusion in SureScreen’s range of lateral flow point of care test kits in the Australian, New Z...

ECS is selling its medicinal cannabis farm in Tasmania Crypto ATMs are now a thing in weed dispensaries in the US Zelira Therapeutics nabs regulatory approval in Germany for insomnia medication Ever fancied your own cannabis farm? Well, t...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

A recent research reveals which biotech segments VCs are ploughing billions of dollars into We list the ASX companies that are operating within those thematics We also list the best and worst ASX biotech performers over the past week and m...

The ASX 200 and XEC small cap indices rise Attention turns to Tuesday’s date with RBA destiny Celsius Resources is hot   The ASX 200 and the Emerging Markets (XEC) indices are both trading higher on Monday up about 1.2%, ahead of tomorrow...

Retail and independent cannabis lounges could be opening soon in Vegas Cann Group gets good manufacturing practice (GMP) licence for its Mildura facility Bod plans to launch a low dose CBD schedule 3 product into the Australian market  ...

A Thai university says adding cannabis to chicken feed has positive results on meat and egg quality Aussie cannabis campaigner now a Member of the Order of Australia MGC Pharma’s CBD treatment proves effective against brain tumors   Chian...

Boston Beer Co launches cannabis iced tea in Canada University of Sydney says using CBD and driving is no worries Emyria reports positive Phase 1 study results for ultra-pure CBD capsule The Boston Beer Co is launching a line of cannabis-...

Actor Woody Harrelson has opened a cannabis store in West Hollywood Releaf has plans for a weed wellness retreat in Byron Bay Incannex wants to buy out APIRx   It’s not surprising that Woody Harrelson loves weed – the actor was actually...

Actor and cannabis farmer Jim Belushi is headlining the Grow Up Conference and Expo next month Franchise Global Health has established the first legal seedbank in Denmark Botanix nabs FDA Qualified Infection Disease Product designation for...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

The Healthcare sector has been struggling as the pandemic wanes But most money managers are still bullish on the sector The biggest movements and news from ASX healthcare stocks this week  Dr Anthony Faucci, America’s top infectious disea...

US Seed Connect launched Cannabis Crypto Seed Headz NFT Washington launches week-long cannabis tax holiday Medlab clinical makes moves in the Northern Hemisphere with manufacturing deal Wednesday was 4/20 day – while it’s more of an unoff...

The healthcare sector is experiencing a dry run IPO listings have fallen significantly on weak market appetite  A snapshot of the return of recent ASX Healthcare IPO stocks We are currently in the longest and steepest bear market for biot...

Rhinomed (ASX: RNO) has successfully completed the institutional component of the partially underwritten accelerated non-renounceable entitlement offer and raised approximately $3.37 million.

It’s been an emotional ride for fans of the ASX200 (XJO) which, alongside the Emerging Companies (XEC) index, (down 0.6%) gave up its early gains in a topsy-turvy Monday session. Just after the close, the XJO was weepingly flat – well, up 0...

Highlights The ASX Small Ordinaries index (ASX:XSO) surged 0.68% to 3,338 by 11:30 AM AEST today. 4DS, RAP and RNO are three penny stocks starting the week with a bang. Investors must do proper due diligence before investing in these...

ResApp gets takeover offer from Pfizer Recce gets Hong Kong patent RhinoMed comes out of trading halt and rallied 20% Smartphone-based health company ResApp Health (ASX:RAP) surprised the market this morning after revealing that global gi...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

S&P/ASX 200 healthcare index modestly up 0.16% for week Gut health company Microba falls on IPO Rhythm Biosciences bowel cancer blood screening test milestone Have a habit of forgetting where you put your keys or mobile phone? You ma...

The ASX lost ground on Thursday. Weak leads out of Wall Street, more threats of Western-led sanctions v. Russia and a more hawkish tone out of the Federal Reserve left the benchmark 0.6% down with a half hour before the closing bell. Follow...

Rhinomed (RNO) finalises an agreement with Canadian rapid antigen test (RAT) kits manufacturer BTNX for supply of swabs The two-year supply agreement covers Rhinoswab and Rhinoswab Junior for inclusion in BTNX’s range of COVID-19 RAT kits...

AdAlta gets first patent in India RhinoMed to start selling Covid swaps and RAT kits in Canada AdAlta (ASX:1AD) has received an Indian patent for its lead program, AD-214. The new patent protects the i-body sequence used in AD-214, as wel...

Biotech sector has had a tough time recently But there are signs of things improving this year A look at biotech movers on the ASX in the past fortnight Biotech stocks entered a bear phase in the middle of 2021, and things haven’t improve...

The ACIC says weed consumption increased in cities and regions ROO receives USA design patent approval for its Heat Exchange Probe EMD has launched its second ultra-pure CBD capsule, the EMD-RX7   The latest Australian Criminal Intelligen...

The ASX Emerging Companies index (XEC) is up more than 1.5% on Thursday, while the benchmark ASX 200 is higher as well. Local investors are totally unconcerned by weak US futures when commodity prices behave like incensed lemmings. The alre...

Highlights The ASX Small Ordinaries index surged over 1.1% to 3,258, by 12:30 PM AEDT. ZBT, FHE and RNO are some ASX penny stocks surging higher today. Proper due diligence is always recommended before investing in penny stocks. T...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Telehealth was already a growing space even before the pandemic, but COVID had launched it into the mainstream. At the height of the pandemic in 2020, data from Research and Markets showed that 76% of hospitals in the US were using teleheal...

And it’s back-to-back gains for the ASX 200 after commodity prices and buying more stuff in December led to a smart 3.4% gain in quarterly GDP. Heading into the close, US futures are on the up. Iron ore is smashing it – up almost 4% to a Ch...

The ASX Emerging Companies index (XEC) ran free on Tuesday, climbing over 3%, apparently unrestrained by the various macro or geopolitical issues bothering the rest of us. That said, the more gown up ASX200 also lifted on Tuesday, gaining a...

Hemp farmers in New York have been given the go ahead to plant cannabis for the 2022 season. The legislation allows conditionally licensed cannabis farmers to grow weed, but they must meet certain requirements, including safe, sustainable a...

The ongoing lawsuit involving Johnson & Johnson (J&J)’s talc products took a controversial turn in the courts this week. The healthcare giant is currently staring down 38,000 claims that its talc products (including the famous baby...

In December France banned the sale of hemp flower and leaf loaded with CBD, but the Conseil d’Etat provisionally overruled the decision on Wednesday – pending further examination of the order. Basically, the French court said that flowers...

Well, that was brutal. After two days of steady falls, local markets executed a proper face-plant on Tuesday as the microcap Emerging Markets index slumped by 5.14%. For some recent history, you’d have to go back to the heady days of March...

Highlights Small cap stocks are in a free-fall mode and the ASX Small Ordinaries index has continued its losing streak for a fifth consecutive day. 1ST, RNO and BLU are some of the ASX penny stocks, showing strength in this bearish mar...

Medicinal cannabis stock Cann Group (ASX:CAN) has scored a regulatory milestone, after being granted a GMP licence to manufacture CBD therapeutic goods in its Southern facility in Victoria. The GMP (or Good Manufacturing Practice) license w...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mov...

At the time of writing, the ASX XHJ Healthcare index is up 5.55% over the last five trading days, beating the ASX200 benchmark index which was up 2.8% for the period. Here’s a table showing how ASX-listed healthcare stocks have been perform...

It’s been a rocky two weeks for small-cap health companies with 42 gaining ground, 76 losing it, and 21 flatlining.   Here’s a table showing how ASX-listed healthcare stocks have been performing. CODE COMPANY PRICE 1 WEEK RETURN %...